San Diego: Getting a Grip on Glia, Part 2
Cell-based therapies have the potential for treating a variety of diseases...
6397 RESULTS
Sort By:
Cell-based therapies have the potential for treating a variety of diseases...
A mini-symposium at this year’s annual meeting of the Society of Neuroscience devoted attention to the role of glia in brain injury and disease...
The earliest signs of Alzheimer disease are bound to be subtle, arising from perturbations in brain function...
To a bird’s eyes, the San Diego convention center for the past 5 days would have looked like a mile-long human beehive...
A new twist on fluorescent tagging for proteins gives researchers a way to track...
The scenario is all too common: a person with dementia can no longer drive safely, yet family members are reluctant to take away the keys...
The Alzforum coverage of the 37th annual conference of the Society for Neuroscience kicks off with a story about...
Genetic variation is what makes a person unique. It also underlies susceptibility to a multitude of human disorders...
Since they were discovered to be a major toxic species, Aβ oligomers have haunted many a research lab...
Aggregated proteins lie at the heart of many neurodegenerative diseases, but researchers have struggled to...
Memories are made, at least in part, from changes in the distribution of synaptic AMPA-type glutamate receptors. In Alzheimer disease...
Los Angeles: People With Memory Loss Speak for Themselves Living Our Lives, Planning Our Futures: Early Memory Loss Forum
On Saturday, 27 October, in Los Angeles, an unusual conference marked a paradigm shift in the Alzheimer disease movement...
Researchers once hotly debated whether non-steroidal anti-inflammatories (NSAIDs) reduce pathology in Alzheimer disease...
From the very start, problems with blood vessels have been recognized as being part of Alzheimer disease...